Radiation and Cancer Biology

SS 27 - Biology 6 - Experimental Therapeutics and Target Discovery

9/17/2019
4:45 PM - 6:00 PM
Location: Room W194

Session Type: Scientific
1.25 AMA PRA Category 1 Credits™
1.25 CAMPEP Credits

Presentations:

ViewAttendees 10 CE Eval

Carmen Bergom, MD, PhD

Medical College of Wisconsin

Disclosure:
Employment
Medical College of Wisconsin: Assistant Professor: Employee;
Medical College of Wisconsin: Resident Physician: Employee

Compensation
Mary Kay Foundation: Research Grants;
NIH: Research Grants;
Susan G. Komen Foundation: Research Grants

Leadership
American Cancer Society: Member;
Radiation Oncology Institute: Member

Biography:
Carmen Bergom, M.D., Ph.D., is an Assistant Professor in Radiation Oncology at the Medical College of Wisconsin (MCW). She treats breast cancer patients at the MCW Cancer Center, and she also has a translational research laboratory focusing on using innovative genetic models to improve the therapeutic ratio radiation therapy by identifying targets to enhance tumor radiosensitivity and minimize normal tissue toxicities.

Presentation(s):

ViewAttendees 10 CE Eval

Send Email for Carmen Bergom

Scott Bratman, MD, PhD

Princess Margaret Hospital

Disclosure:
Employment
University Health Network: Staff Radiation Oncologist - Clinician Scientist: Employee

Ownership
Royalty: Inventor on Patent: Roche molecular diagnostics 

Biography:
Dr. Scott Bratman is an Assistant Professor of Radiation Oncology and Medical Biophysics at the University of Toronto, where he has been on faculty since 2014. Dr. Bratman also serves as Clinician-Scientist and Staff Radiation Oncologist at The Princess Margaret Cancer Centre. Dr. Bratman was trained at Princeton University, Columbia University Medical Center, and Stanford Cancer Institute. Starting with his postdoctoral studies at Stanford, Dr. Bratman has co-developed cutting-edge liquid biopsy technologies for detection and monitoring of cancer in the bloodstream. This work is revolutionizing cancer care by allowing non-invasive diagnosis and novel precision medicine strategies. As a clinician-scientist, Dr. Bratman is at the front lines of translating liquid biopsies into improved health outcomes. His research program includes projects on head and neck cancer, cervix cancer, and leukemia. The Bratman Lab is also developing genomic tools for personalized use of radiotherapy.

Presentation(s):

ViewAttendees 10 CE Eval

Send Email for Scott Bratman


Assets

SS 27 - Biology 6 - Experimental Therapeutics and Target Discovery



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for SS 27 - Biology 6 - Experimental Therapeutics and Target Discovery